Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Belenos Biosciences Inc.

Headquarters: United States of America
Website: N/A
Year Founded: 2024
Status: Private

BioCentury | Mar 3, 2025
Deals

The dealmaking at the heart of the NewCo boom

Formed with Hummingbird assets, $187M, Callio brings trend to Singapore
BioCentury | Jan 29, 2025
Deals

The NewCo boom signals China’s galloping speed of innovation

Companies founded in the West with Asian assets tell a story of China speed
BioCentury | Nov 14, 2024
Data Byte

Cross-border trends in uncertain times for China biotech

A new start-up model and licensing deals fueled by new modalities sustain the momentum of China biotech’s innovation engine
BioCentury | Nov 8, 2024
Editor's Commentary

China biotech and the bear: a Perspective

Deal-making with the West offers a path through uncertain times, but in what position will China biotechs emerge from the bear?
BioCentury | Oct 22, 2024
Product Development

Newco trend watch: Clusters of launches point to areas undergoing derisking

Oligo delivery to the kidney, and two emerging use cases for T cell engagers, each get newcos; most with mega-
BioCentury | Sep 10, 2024
Emerging Company Profile

Candid: Bispecifics for autoimmunity, leveraging Chinese oncology innovation

Ken Song’s post-RayzeBio venture pulled together two licensing deals, an M&A transaction and three financings totaling $370M 
Items per page:
1 - 6 of 6